What's Helping What We Do?

These are the positive forces at work in our strategy/ program that influence how much we do or how well we do it.

•   Vaccines available for both private insurance carriers and medicaid recipients
•    Social media advertisement of Covid-19 vaccine
•    All nurses trained to administer vaccines to help speed up immunization appointments
•    Educational material on Covid-19 vaccine
•   The availability of several brands to offer

What's Hurting What We Do?

These are the negative forces at work in our strategy/program that influence how much we do or how well we do it.

•   Stagima surrounding Covid-19 vaccine
•   Waiting times for vaccines to arrive at health department   
•   CVMS database troubleshooting

The following actions have been identified by CHA Team as ideas for what can work for this performance measure to make a difference on Prevention and Management of Acute Respiratory Infections.

(A) Actions and Approaches Identified by Our CHA Team. These are actions and approaches that we think can make a difference for this performance measure.

• Influenza, Pneumonia, and COVID-19 vaccines to help decrease the effects from these viruses
• Monoclonal Antibody treatment
• Early detection of an illness
• Proper use of an incentive spirometer
• Information/education on these infections

(B) No-cost and Low-cost Ideas Identified by Our CHA Team. These are no-cost and low-cost actions and approaches that we think can make a difference for this performance measure.

• Providing education to individuals about signs of Respiratory Distress
• Immunizations are covered by most insurance companies

(C) What your customers think would work to do better. These are actions and approaches that our customers think can make a difference for this performance measure.

• Increase vaccinations
• Monoclonal Antibodies

(D) List of Questions/Research Agenda These are questions to follow-up on for this performance measure. 

• Did we see an improvement with Covid-19 patients after receiving Monoclonal Antibodies?
• Does vaccines lessen the effects of these respiratory illnesses?
• Does early detection make a difference with treatment?